2021
3/5/2022
3/5/2022
Annual Results for the twelve months ended 31 December 2020
3/31/2021
3/31/2021
Convatec awarded contract for Ostomy Products from Vizient, Inc.
4/29/2021
4/29/2021
Trading update for the three months ended 31 March 2021
6/21/2021
6/21/2021
Global commercial rights signed by Convatec Ltd for ChloraSolv, innovative wound debrider from RLS
7/30/2021
7/30/2021
Interim Results for the six months ended 30 June 2021
9/30/2021
9/30/2021
Convatec Group Plc Announces Offering of $500 Million Senior Notes due 2029
10/1/2021
10/1/2021
Convatec Group Plc Announces Pricing of $500 Million 3.875% Senior Notes due 2029
5/13/2022
5/13/2022
Trading update for the three months ended 30 September 2021
5/13/2022
5/13/2022
Convatec awarded contract for Advanced Wound Care Products from Vizient, Inc.
5/13/2022
5/13/2022
25 years of AQUACEL
5/13/2022
5/13/2022
